Vanda Pharmaceuticals (VNDA) Finished Goods (2014 - 2018)

Vanda Pharmaceuticals has disclosed Finished Goods across 5 years of filings, most recently posting $1.0 million for Q1 2018.

• Finished Goods for Q1 2018 came in at $1.0 million, up 31.98% year-over-year; the trailing twelve-month figure through Mar 2018 was $1.0 million (up 31.98% YoY), and the FY2017 annual result was $760000.0, changed 0.26% from the prior year.
• Finished Goods came in at $1.0 million for Q1 2018 at Vanda Pharmaceuticals, up from $760000.0 in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $3.4 million in Q4 2014 to a low of $611000.0 in Q2 2017.
• The 5-year median for Finished Goods is $941000.0 (2014), against an average of $1.5 million.
• Peak annual rise in Finished Goods reached 181.19% in 2015, while the deepest fall reached 61.87% in 2015.
• Vanda Pharmaceuticals' Finished Goods stood at $3.4 million in 2014, then plunged by 61.87% to $1.3 million in 2015, then sank by 41.11% to $762000.0 in 2016, then decreased by 0.26% to $760000.0 in 2017, then surged by 33.03% to $1.0 million in 2018.
• The last three Finished Goods figures came in at $1.0 million (Q1 2018), $760000.0 (Q4 2017), and $858000.0 (Q3 2017), per Business Quant data.